Skip to content

Long-term clinical trial on tolerability, toxicity, pharmacokinetics and molecular mechanisms of action of EPI-EE

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-520751-83-00
Enrollment
15
Registered
2025-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eosinophilic Esophagitis as a archetype of chronic inflammatory digestive disease

Interventions

None listed

Sponsors

Hospital General De Tomelloso
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026